{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:00:36Z","timestamp":1762506036109},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s11934-013-0305-1","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T10:52:17Z","timestamp":1358938337000},"page":"102-108","source":"Crossref","is-referenced-by-count":10,"title":["Conservative Nephron-Sparing Treatment of Upper-Tract Tumors"],"prefix":"10.1007","volume":"14","author":[{"given":"Paul","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"4","key":"305_CR1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0094-0143(05)70123-3","volume":"27","author":"DG Assimos","year":"2000","unstructured":"Assimos DG, Hall MC, Martin JH. Ureteroscopic management of patients with upper tract transitional cell carcinoma. Urol Clin North Am. 2000;27(4):751\u201360.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"305_CR2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.urolonc.2004.10.010","volume":"23","author":"DW Soderdahl","year":"2005","unstructured":"Soderdahl DW, et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol. 2005;23(2):114\u201322.","journal-title":"Urol Oncol"},{"issue":"5","key":"305_CR3","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164(5):1523\u20135.","journal-title":"J Urol"},{"issue":"1","key":"305_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0094-0143(03)00099-5","volume":"31","author":"JS Lam","year":"2004","unstructured":"Lam JS, Gupta M. Ureteroscopic management of upper tract transitional cell carcinoma. Urol Clin North Am. 2004;31(1):115\u201328.","journal-title":"Urol Clin North Am"},{"issue":"8","key":"305_CR5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ncpuro0875","volume":"4","author":"JD Raman","year":"2007","unstructured":"Raman JD, Scherr DS. Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol. 2007;4(8):432\u201343.","journal-title":"Nat Clin Pract Urol"},{"issue":"6","key":"305_CR6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-5347(17)59010-2","volume":"116","author":"H Zincke","year":"1976","unstructured":"Zincke H, et al. Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract. J Urol. 1976;116(6):781\u20133.","journal-title":"J Urol"},{"issue":"1","key":"305_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-5347(01)65273-X","volume":"157","author":"FX Keeley","year":"1997","unstructured":"Keeley FX, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157(1):33\u20137.","journal-title":"J Urol"},{"issue":"6","key":"305_CR8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1464-410X.2005.05402.x","volume":"95","author":"GD Stewart","year":"2005","unstructured":"Stewart GD, et al. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int. 2005;95(6):791\u20133.","journal-title":"BJU Int"},{"issue":"4","key":"305_CR9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.urology.2011.12.024","volume":"79","author":"BT Ristau","year":"2012","unstructured":"Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial carcinoma: current treatment and outcomes. Urology. 2012;79(4):749\u201356.","journal-title":"Urology"},{"key":"305_CR10","unstructured":"\u2022 NCCN Clinical Practice Guidelines in Oncology--Bladder Cancer. 2013; 1.2013:[Available from: www.nccn.org. Current NCCN guidelines emphasizing that segmental ureteral resection is a reasonable treatment option for patients with low grade UTUC of the middle or distal ureter."},{"issue":"3","key":"305_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000471981","volume":"2","author":"E Mazeman","year":"1976","unstructured":"Mazeman E. Tumours of the upper urinary tract calyces, renal pelvis and ureter. Eur Urol. 1976;2(3):120\u20136.","journal-title":"Eur Urol"},{"issue":"4","key":"305_CR12","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.juro.2009.12.018","volume":"183","author":"C Jeldres","year":"2010","unstructured":"\u2022 Jeldres C, et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol. 2010;183(4):1324\u20139. Recent SEER database study highlighting that segmental ureterectomy confers equivalent oncologic outcomes as radical nephroureterectomy.","journal-title":"J Urol"},{"issue":"5","key":"305_CR13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.eururo.2006.11.021","volume":"51","author":"J Lehmann","year":"2007","unstructured":"Lehmann J, et al. Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol. 2007;51(5):1281\u20138.","journal-title":"Eur Urol"},{"issue":"3","key":"305_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ucl.2008.05.010","volume":"35","author":"GN Box","year":"2008","unstructured":"Box GN, et al. Minimally invasive management of upper tract malignancies: renal cell and transitional cell carcinoma. Urol Clin North Am. 2008;35(3):365\u201383. vii.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"305_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00345-010-0525-7","volume":"28","author":"DH Bagley","year":"2010","unstructured":"Bagley DH, Grasso 3rd M. Ureteroscopic laser treatment of upper urinary tract neoplasms. World J Urol. 2010;28(2):143\u20139.","journal-title":"World J Urol"},{"issue":"4","key":"305_CR16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0022-5347(05)67135-2","volume":"164","author":"GL Chen","year":"2000","unstructured":"Chen GL, Bagley DH. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol. 2000;164(4):1173\u20136.","journal-title":"J Urol"},{"issue":"1","key":"305_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cncr.11446","volume":"98","author":"S Daneshmand","year":"2003","unstructured":"Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer. 2003;98(1):55\u201360.","journal-title":"Cancer"},{"issue":"2","key":"305_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0090-4295(01)01109-8","volume":"58","author":"DS Elliott","year":"2001","unstructured":"Elliott DS, et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58(2):174\u20138.","journal-title":"Urology"},{"issue":"5","key":"305_CR19","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0022-5347(01)64793-1","volume":"157","author":"FX Keeley Jr","year":"1997","unstructured":"Keeley Jr FX, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 1997;157(5):1560\u20135.","journal-title":"J Urol"},{"issue":"2 Pt 1","key":"305_CR20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005392-199608000-00011","volume":"156","author":"JA Martinez-Pineiro","year":"1996","unstructured":"Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol. 1996;156(2 Pt 1):377\u201385.","journal-title":"J Urol"},{"issue":"6","key":"305_CR21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2005.12.034","volume":"67","author":"M Roupret","year":"2006","unstructured":"Roupret M, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67(6):1181\u20137.","journal-title":"Urology"},{"issue":"2","key":"305_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-410X.2008.07535.x","volume":"102","author":"SM Lucas","year":"2008","unstructured":"Lucas SM, et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int. 2008;102(2):172\u20136.","journal-title":"BJU Int"},{"issue":"4","key":"305_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.urology.2007.11.018","volume":"71","author":"RH Thompson","year":"2008","unstructured":"Thompson RH, et al. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology. 2008;71(4):713\u20137.","journal-title":"Urology"},{"issue":"4","key":"305_CR24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0094-0143(05)70122-1","volume":"27","author":"ME Jabbour","year":"2000","unstructured":"Jabbour ME, Smith AD. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am. 2000;27(4):739\u201350.","journal-title":"Urol Clin North Am"},{"issue":"4","key":"305_CR25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/089277901300189385","volume":"15","author":"EN Liatsikos","year":"2001","unstructured":"Liatsikos EN, et al. Transitional-cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. J Endourol. 2001;15(4):377\u201383. discussion 397.","journal-title":"J Endourol"},{"issue":"1","key":"305_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.ju.0000132128.79974.db","volume":"172","author":"J Palou","year":"2004","unstructured":"Palou J, et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol. 2004;172(1):66\u20139.","journal-title":"J Urol"},{"issue":"1","key":"305_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2008.06.026","volume":"73","author":"AR Rastinehad","year":"2009","unstructured":"\u2022 Rastinehad AR, et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guerin therapy? Urology. 2009;73(1):27\u201331. Large, contemporary series highlighting the therapeutic efficacy of BCG used in an adjuvant setting following endoscopic management of UTUC.","journal-title":"Urology"},{"issue":"4","key":"305_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/end.1999.13.289","volume":"13","author":"BR Lee","year":"1999","unstructured":"Lee BR, et al. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes. J Endourol. 1999;13(4):289\u201394.","journal-title":"J Endourol"},{"issue":"5","key":"305_CR29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0022-5347(01)66732-6","volume":"154","author":"TW Jarrett","year":"1995","unstructured":"Jarrett TW, et al. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol. 1995;154(5):1629\u201335.","journal-title":"J Urol"},{"issue":"3","key":"305_CR30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/01.ju.0000050242.68745.4d","volume":"169","author":"MC Goel","year":"2003","unstructured":"Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol. 2003;169(3):925\u20139. discussion 929\u201330.","journal-title":"J Urol"},{"issue":"Suppl 1","key":"305_CR31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1100\/tsw.2004.49","volume":"4","author":"PE Clark","year":"2004","unstructured":"Clark PE, Streem SB. Endourologic management of upper tract transitional cell carcinoma. Scie World J. 2004;4 Suppl 1:62\u201375.","journal-title":"Scie World J"},{"issue":"4","key":"305_CR32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/end.2008.0164","volume":"23","author":"AR Rastinehad","year":"2009","unstructured":"Rastinehad AR, Smith AD. Bacillus Calmette-Guerin for upper tract urothelial cancer: is there a role? J Endourol. 2009;23(4):563\u20138.","journal-title":"J Endourol"},{"issue":"4 Pt 1","key":"305_CR33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-5347(05)64454-0","volume":"168","author":"GN Thalmann","year":"2002","unstructured":"Thalmann GN, et al. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168(4 Pt 1):1381\u20135.","journal-title":"J Urol"},{"issue":"6","key":"305_CR34","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/S0022-5347(01)68157-6","volume":"158","author":"FX Keeley Jr","year":"1997","unstructured":"Keeley Jr FX, Bagley DH. Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. J Urol. 1997;158(6):2074\u20137.","journal-title":"J Urol"},{"key":"305_CR35","doi-asserted-by":"crossref","unstructured":"Bin, X., et al. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours. BJU Int, 2012.","DOI":"10.1111\/j.1464-410X.2012.11199.x"},{"issue":"2","key":"305_CR36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1464-410X.2007.06993.x","volume":"100","author":"G Giannarini","year":"2007","unstructured":"Giannarini G, et al. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? BJU Int. 2007;100(2):264\u20138.","journal-title":"BJU Int"},{"issue":"3","key":"305_CR37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000473759","volume":"29","author":"A Leitenberger","year":"1996","unstructured":"Leitenberger A, Beyer A, Altwein JE. Organ-sparing treatment for ureteral carcinoma? Eur Urol. 1996;29(3):272\u20138.","journal-title":"Eur Urol"},{"issue":"4","key":"305_CR38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0094-0143(21)00778-3","volume":"11","author":"H Zincke","year":"1984","unstructured":"Zincke H, Neves RJ. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol Clin North Am. 1984;11(4):717\u201324.","journal-title":"Urol Clin North Am"},{"issue":"3","key":"305_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/end.2010.0276","volume":"25","author":"EM Raymundo","year":"2011","unstructured":"Raymundo EM, et al. Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol. 2011;25(3):377\u201384.","journal-title":"J Endourol"},{"issue":"2","key":"305_CR40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00345-009-0494-x","volume":"28","author":"JN Cornu","year":"2010","unstructured":"Cornu JN, et al. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol. 2010;28(2):151\u20136.","journal-title":"World J Urol"},{"issue":"3","key":"305_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/end.2008.0251","volume":"23","author":"RW Pak","year":"2009","unstructured":"Pak RW, Moskowitz EJ, Bagley DH. What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol. 2009;23(3):341\u20136.","journal-title":"J Endourol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-013-0305-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-013-0305-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-013-0305-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T16:17:35Z","timestamp":1644164255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-013-0305-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1007\/s11934-013-0305-1","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}